Skip to main content
WELLELL logo

WELLELL — Investor Relations & Filings

Ticker · 4106 ISIN · TW0004106000 TW Manufacturing
Open in API
Filings indexed 1,626 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 4106

About WELLELL

https://tw.wellell.com/zh-tw

Wellell, formerly known as APEX Medical, is a global developer and manufacturer of medical solutions specializing in pressure relief and respiratory therapy. Established in 1990, the company focuses on improving the quality of life for patients and caregivers through advanced clinical equipment. Its core product portfolio includes medical air mattress systems for pressure injury prevention, continuous positive airway pressure (CPAP) devices for obstructive sleep apnea, and compression therapy systems for venous thromboembolism (VTE) intervention. Wellell integrates digital health technologies to create a Patient Recovery Care (PRC) ecosystem, enhancing treatment efficiency in both acute and post-acute care settings. With over 35 years of expertise, the company provides evidence-based medical devices and digital health services to support inpatient and outpatient recovery globally.

Recent filings

Filing Released Lang Actions
115年第1季財務報告書 — 202601_4106_AI1.pdf
Interim / Quarterly Report Classification · 92% confidence The document is the consolidated financial report for 雅博股份有限公司 and its subsidiaries for the first quarter (民國115年及114年第一季), including a KPMG auditors’ review report and full interim financial statements (balance sheet, income statement, cash flow, equity, and detailed notes). It contains actual quarterly financial data and analysis, not merely an announcement or certification. This fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document is from Taiwan’s Market Observation Post System (公開資訊觀測站) and is titled “115年1季申報作業” (Q1 filing operations). It contains actual financial data (equity‐method investment balances and recognized profit/loss) for the quarter rather than a notice announcing or linking to a report. This level of substantive period financial disclosure is consistent with an interim/quarterly report (季報), so it should be classified as IR. Q1 2026
2026-05-14 Chinese
115年第1季大陸投資
Regulatory Filings Classification · 80% confidence The document is a standalone table disclosing the company’s Mainland China investment details for Q1 of ROC Year 115, provided to Taiwan’s public information observatory. It does not constitute a complete interim/quarterly report with full financial statements, nor is it an announcement of a broader report or a standard form like an earnings release or M&A notice. This specialized disclosure is best classified under general regulatory filings that don’t fit other specific categories.
2026-05-14 Chinese
公告本公司民國115年度第一季合併財務報告業經提報董事會
Interim / Quarterly Report Classification · 88% confidence The text is a first‐quarter consolidated financial report (民國115年度第一季合併財務報告) filed on the public disclosure system, including actual numeric data (revenue, profit, assets, liabilities, EPS) and board/audit committee approval dates. This clearly constitutes an Interim/Quarterly Report rather than merely an announcement or press release. Therefore it is classified as IR. Q1 2026
2026-05-12 Chinese
補充公告本公司董事會決議召開115年股東常會相關事宜 (因應電子投票自動轉入格式規定，故配合重新上傳)
Proxy Solicitation & Information Statement Classification · 89% confidence The document is a supplemental announcement by the company’s board resolving to convene the 115th Annual General Shareholders’ Meeting. It provides meeting date, location, agenda items (reporting, approval and discussion matters), and e‐voting arrangements—all elements of shareholder meeting notification and proxy information. This aligns with “Proxy Solicitation & Information Statement (PSI)” as it is the formal information distributed to shareholders in advance of the meeting to inform and solicit votes.
2026-05-12 Chinese
補充公告本公司董事會決議召開115年股東常會相關事宜
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal convocation/agenda notice for the upcoming annual general meeting (AGM), detailing the board resolution date, meeting date, location, meeting agenda (report items, approval items, discussion items), proxy voting period, and electronic voting details. This type of document constitutes materials sent to shareholders to provide information and request votes for a shareholders’ meeting, matching the description of a Proxy Solicitation & Information Statement.
2026-05-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.